Dekkers Ilona A, Lamb Hildo J
1 Department of Radiology, Leiden University Medical Center , Leiden , The Netherlands.
Br J Radiol. 2018 Dec;91(1092):20170825. doi: 10.1259/bjr.20170825. Epub 2018 Jul 23.
Pathological tissue alterations due to disease processes such as fibrosis, edema and infiltrative disease can be non-invasively visualized and quantified by MRI using T and T relaxation properties. Pixel-wise mapping of T and T image sequences enable direct quantification of T, T(), and extracellular volume values of the target organ of interest. Tissue characterization based on T and T() mapping is currently making the transition from a research tool to a clinical modality, as clinical usefulness has been established for several diseases such as myocarditis, amyloidosis, Anderson-Fabry and iron deposition. Other potential clinical applications besides the heart include, quantification of steatosis, cirrhosis, hepatic siderosis and renal fibrosis. Here, we provide an overview of potential clinical applications of T andT() mapping for imaging of cardiac, liver and renal disease. Furthermore, we give an overview of important technical considerations necessary for clinical implementation of quantitative parametric imaging, involving data acquisition, data analysis, quality assessment, and interpretation. In order to achieve clinical implementation of these techniques, standardization of T and T() mapping methodology and validation of impact on clinical decision making is needed.
诸如纤维化、水肿和浸润性疾病等病理过程引起的组织病理改变,可以通过磁共振成像(MRI)利用T1和T2弛豫特性进行无创可视化和量化。T1和T2图像序列的逐像素映射能够直接量化感兴趣的目标器官的T1、T2以及细胞外容积值。基于T1和T2映射的组织特征分析目前正从一种研究工具向临床模式转变,因为已经确定其对心肌炎、淀粉样变性、安德森-法布里病和铁沉积等多种疾病具有临床实用性。除心脏外的其他潜在临床应用还包括脂肪变性、肝硬化、肝铁沉积和肾纤维化的量化。在此,我们概述了T1和T2映射在心脏、肝脏和肾脏疾病成像中的潜在临床应用。此外,我们还概述了定量参数成像临床应用所需考虑的重要技术因素,包括数据采集、数据分析、质量评估和解读。为了实现这些技术的临床应用,需要对T1和T2映射方法进行标准化,并验证其对临床决策的影响。